Cecilia Boccalini

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Clinical and Biologic Characterization of a 3-Level Centiloid-Based Classification of Amyloid PET.

Clinical and Biologic Characterization of a 3-Level Centiloid-Based Classification of Amyloid PET.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 31, 2026

Clinical amyloid and tau positron emission tomography imaging in Alzheimer's disease: image interpretation in the era of anti-amyloid therapies.

Clinical amyloid and tau positron emission tomography imaging in Alzheimer's disease: image interpretation in the era of anti-amyloid therapies.

Journal: Current opinion in neurology
Published: February 20, 2026

Investigating AD and non-AD [18F]flortaucipir distribution patterns in a memory clinic cohort.

Investigating AD and non-AD [18F]flortaucipir distribution patterns in a memory clinic cohort.

Journal: European journal of nuclear medicine and molecular imaging
Published: January 20, 2026

Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Journal: Neurology
Published: September 12, 2025

Is early-phase amyloid PET ready for use as neurodegeneration marker?

Is early-phase amyloid PET ready for use as neurodegeneration marker?

Journal: Journal of Alzheimer's disease : JAD
Published: August 14, 2025

Hypoperfusion in early-phase amyloid PET as a predictor of cognitive decline in Alzheimer's disease.

Hypoperfusion in early-phase amyloid PET as a predictor of cognitive decline in Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging
Published: August 14, 2025

Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers.

Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers.

Journal: European journal of clinical investigation
Published: July 18, 2025

Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease.

Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease.

Journal: Neurology
Published: May 13, 2025

Comparison of two preprocessing methods for 18F-Flortaucipir PET quantification in Alzheimer's disease.

Comparison of two preprocessing methods for 18F-Flortaucipir PET quantification in Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging
Published: May 09, 2025

Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission.

Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission.

Journal: Handbook of clinical neurology
Published: May 08, 2025

Mapping the neural correlates of the effect of psycholinguistic variables on picture naming performance: a FDG-PET study across neurodegenerative diseases.

Mapping the neural correlates of the effect of psycholinguistic variables on picture naming performance: a FDG-PET study across neurodegenerative diseases.

Journal: Alzheimer's research & therapy
Published: April 30, 2025

Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment.

Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment.

Journal: European journal of nuclear medicine and molecular imaging
Published: January 16, 2025
Showing 1-12 of 40

Last Updated: 09/26/2026